Back to Journals » Drug Design, Development and Therapy » Volume 11

A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers

Total article views   HTML views PDF downloads Totals
13,365 Dovepress* 12,594+ 1,402 13,996
PubMed Central* 771 244 1,015
Totals 13,365 1,646 15,011
*Since 24 April 2017
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar